BI1744

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI1744, covering 2015-08-17 to 2015-08-17. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of 4 Weeks of Treatment With Orally Inhaled BI1744/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

See pricing